Mentice AB (ST:MNTC) — Market Cap & Net Worth
Market Cap & Net Worth: Mentice AB (MNTC)
Mentice AB (ST:MNTC) has a market capitalization of $38.44 Million (Skr357.20 Million) as of May 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #22824 globally and #427 in its home market, demonstrating a -1.93% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mentice AB's stock price Skr12.70 by its total outstanding shares 28125735 (28.13 Million). Analyse MNTC cash flow conversion to see how efficiently the company converts income to cash.
Mentice AB Market Cap History: 2019 to 2026
Mentice AB's market capitalization history from 2019 to 2026. Data shows change from $222.47 Million to $38.44 Million (-21.60% CAGR).
Index Memberships
Mentice AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$14.99 Billion | 0.26% | #73 of 281 |
Weight: Mentice AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Mentice AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mentice AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.27x
Mentice AB's market cap is 0.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $222.47 Million | $149.37 Million | -$20.60 Million | 1.49x | N/A |
| 2020 | $252.74 Million | $137.50 Million | -$13.09 Million | 1.84x | N/A |
| 2021 | $298.44 Million | $185.06 Million | -$29.19 Million | 1.61x | N/A |
| 2022 | $114.41 Million | $217.95 Million | -$30.66 Million | 0.52x | N/A |
| 2023 | $144.38 Million | $273.61 Million | -$2.82 Million | 0.53x | N/A |
| 2024 | $77.18 Million | $290.33 Million | -$18.42 Million | 0.27x | N/A |
Competitor Companies of MNTC by Market Capitalization
Companies near Mentice AB in the global market cap rankings as of May 4, 2026.
Key companies related to Mentice AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
Mentice AB Historical Marketcap From 2019 to 2026
Between 2019 and today, Mentice AB's market cap moved from $222.47 Million to $ 38.44 Million, with a yearly change of -21.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr38.44 Million | -4.87% |
| 2025 | Skr40.41 Million | -47.65% |
| 2024 | Skr77.18 Million | -46.54% |
| 2023 | Skr144.38 Million | +26.19% |
| 2022 | Skr114.41 Million | -61.66% |
| 2021 | Skr298.44 Million | +18.08% |
| 2020 | Skr252.74 Million | +13.61% |
| 2019 | Skr222.47 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of Mentice AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.44 Million USD |
| MoneyControl | $38.44 Million USD |
| MarketWatch | $38.44 Million USD |
| marketcap.company | $38.44 Million USD |
| Reuters | $38.44 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more